{"transactions":[{"id":739111,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T16:05:03.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":25800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 11, 2027 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":25800,"derivative":{"exercise_price":17.1,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":25800},"source":{"system":"sec-edgar","filing":"0001193125-26-269368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743029/000119312526269368/ownership.xml","form_type":"4"}},{"id":1109380,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T16:05:06.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":30700,"derivative":{"exercise_price":4.91,"expiration_date":"2035-06-13","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0000950170-25-086701","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743029/000095017025086701/ownership.xml","form_type":"4"}},{"id":1480140,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T16:30:12.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":22100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2025 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":22100,"derivative":{"exercise_price":4.16,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":22100},"source":{"system":"sec-edgar","filing":"0000950170-24-073073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743029/000095017024073073/ownership.xml","form_type":"4"}},{"id":1853758,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T16:28:50.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 14, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":20500,"derivative":{"exercise_price":6.59,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001209191-23-037354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743029/000120919123037354/doc4.xml","form_type":"4"}},{"id":2229429,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T16:32:28.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2023 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":15000,"derivative":{"exercise_price":7.66,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037432","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743029/000120919122037432/doc4.xml","form_type":"4"}},{"id":2654352,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T17:01:02.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":47132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option shall vest in 36 substantially equal monthly installments, with the first installment vesting on June 28, 2021."}],"balance_after":47132,"derivative":{"exercise_price":19,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":47132},"source":{"system":"sec-edgar","filing":"0000899243-21-025977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743029/000089924321025977/doc4.xml","form_type":"4"}},{"id":2654351,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T17:01:02.000Z","date":"2021-04-12","kind":"grant","acquired":true,"shares":7081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction occurred prior to the Issuer's initial public offering, and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest and become exercisable on April 9, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."}],"balance_after":7081,"derivative":{"exercise_price":6.14,"expiration_date":"2031-04-12","underlying":"Common Stock","underlying_shares":7081},"source":{"system":"sec-edgar","filing":"0000899243-21-025977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743029/000089924321025977/doc4.xml","form_type":"4"}},{"id":3345488,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-11T16:44:56.000Z","date":"2019-12-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":152191,"derivative":{"exercise_price":0.59,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-028932","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028932/doc4.xml","form_type":"4"}},{"id":3345487,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-12-11T16:44:56.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":901,"price":60.0456,"value":54101.0856,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $60.01 to $60.115 per share."}],"balance_after":36470,"source":{"system":"sec-edgar","filing":"0000899243-19-028932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028932/doc4.xml","form_type":"4"}},{"id":3345486,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-12-11T16:44:56.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":9099,"price":59.6185,"value":542468.7315,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $59.00 to $59.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 1 and 2."}],"balance_after":37371,"source":{"system":"sec-edgar","filing":"0000899243-19-028932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028932/doc4.xml","form_type":"4"}},{"id":3345485,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-12-11T16:44:56.000Z","date":"2019-12-09","kind":"exercise","acquired":true,"shares":10000,"price":0.59,"value":5900.0,"ownership":{"direct":true},"balance_after":46470,"source":{"system":"sec-edgar","filing":"0000899243-19-028932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028932/doc4.xml","form_type":"4"}},{"id":3351069,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T17:49:39.000Z","date":"2019-12-04","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":162191,"derivative":{"exercise_price":0.59,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-028602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/doc4.xml","form_type":"4"}},{"id":3351068,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T17:49:39.000Z","date":"2019-12-03","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":172191,"derivative":{"exercise_price":0.59,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-028602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/doc4.xml","form_type":"4"}},{"id":3351067,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-12-05T17:49:39.000Z","date":"2019-12-04","kind":"sale","acquired":false,"shares":1200,"price":59.3932,"value":71271.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold from $59.125 to $59.58 per share."}],"balance_after":36470,"source":{"system":"sec-edgar","filing":"0000899243-19-028602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/doc4.xml","form_type":"4"}},{"id":3351066,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-12-05T17:49:39.000Z","date":"2019-12-04","kind":"sale","acquired":false,"shares":8800,"price":58.599,"value":515671.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $58.11 to $59.10 per share."}],"balance_after":37670,"source":{"system":"sec-edgar","filing":"0000899243-19-028602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/doc4.xml","form_type":"4"}},{"id":3351065,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-12-05T17:49:39.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":10000,"price":0.59,"value":5900.0,"ownership":{"direct":true},"balance_after":46470,"source":{"system":"sec-edgar","filing":"0000899243-19-028602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/doc4.xml","form_type":"4"}},{"id":3351064,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-12-05T17:49:39.000Z","date":"2019-12-03","kind":"sale","acquired":false,"shares":4000,"price":59.6457,"value":238582.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $59.37 to $60.35 per share."}],"balance_after":36470,"source":{"system":"sec-edgar","filing":"0000899243-19-028602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/doc4.xml","form_type":"4"}},{"id":3351063,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-12-05T17:49:39.000Z","date":"2019-12-03","kind":"sale","acquired":false,"shares":5400,"price":58.9504,"value":318332.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $58.37 to $59.225 per share."}],"balance_after":40470,"source":{"system":"sec-edgar","filing":"0000899243-19-028602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/doc4.xml","form_type":"4"}},{"id":3351062,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-12-05T17:49:39.000Z","date":"2019-12-03","kind":"sale","acquired":false,"shares":600,"price":57.8212,"value":34692.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $57.275 to $58.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 1 through 5."}],"balance_after":45870,"source":{"system":"sec-edgar","filing":"0000899243-19-028602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/doc4.xml","form_type":"4"}},{"id":3351061,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-12-05T17:49:39.000Z","date":"2019-12-03","kind":"exercise","acquired":true,"shares":10000,"price":0.59,"value":5900.0,"ownership":{"direct":true},"balance_after":46470,"source":{"system":"sec-edgar","filing":"0000899243-19-028602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/doc4.xml","form_type":"4"}},{"id":3361305,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T21:00:22.000Z","date":"2019-11-21","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":182191,"derivative":{"exercise_price":0.59,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-028027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/doc4.xml","form_type":"4"}},{"id":3361304,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T21:00:22.000Z","date":"2019-11-21","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":192191,"derivative":{"exercise_price":0.59,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-028027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/doc4.xml","form_type":"4"}},{"id":3361303,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-11-22T21:00:22.000Z","date":"2019-11-22","kind":"sale","acquired":false,"shares":601,"price":55.2949,"value":33232.2349,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $55.21 to $55.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":36470,"source":{"system":"sec-edgar","filing":"0000899243-19-028027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/doc4.xml","form_type":"4"}},{"id":3361302,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-11-22T21:00:22.000Z","date":"2019-11-22","kind":"sale","acquired":false,"shares":9399,"price":54.7105,"value":514223.9895,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $54.21 to $55.19 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":37071,"source":{"system":"sec-edgar","filing":"0000899243-19-028027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/doc4.xml","form_type":"4"}},{"id":3361301,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-11-22T21:00:22.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":10000,"price":0.59,"value":5900.0,"ownership":{"direct":true},"balance_after":46470,"source":{"system":"sec-edgar","filing":"0000899243-19-028027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/doc4.xml","form_type":"4"}},{"id":3361300,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-11-22T21:00:22.000Z","date":"2019-11-21","kind":"sale","acquired":false,"shares":200,"price":56,"value":11200.0,"ownership":{"direct":true},"balance_after":36470,"source":{"system":"sec-edgar","filing":"0000899243-19-028027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/doc4.xml","form_type":"4"}},{"id":3361299,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-11-22T21:00:22.000Z","date":"2019-11-21","kind":"sale","acquired":false,"shares":24800,"price":55.116,"value":1366876.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $55.00 to $55.90 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":36670,"source":{"system":"sec-edgar","filing":"0000899243-19-028027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/doc4.xml","form_type":"4"}},{"id":3361298,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-11-22T21:00:22.000Z","date":"2019-11-21","kind":"exercise","acquired":true,"shares":25000,"price":0.59,"value":14750.0,"ownership":{"direct":true},"balance_after":61470,"source":{"system":"sec-edgar","filing":"0000899243-19-028027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/doc4.xml","form_type":"4"}},{"id":3462552,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-12T16:05:23.000Z","date":"2019-07-10","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":217191,"derivative":{"exercise_price":0.59,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-19-019526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319019526/doc4.xml","form_type":"4"}},{"id":3462551,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-07-12T16:05:23.000Z","date":"2019-07-10","kind":"sale","acquired":false,"shares":5000,"price":39.37,"value":196850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold from $39.24 to $39.76 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":36470,"source":{"system":"sec-edgar","filing":"0000899243-19-019526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319019526/doc4.xml","form_type":"4"}},{"id":3462550,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-07-12T16:05:23.000Z","date":"2019-07-10","kind":"exercise","acquired":true,"shares":5000,"price":0.59,"value":2950.0,"ownership":{"direct":true},"balance_after":41470,"source":{"system":"sec-edgar","filing":"0000899243-19-019526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319019526/doc4.xml","form_type":"4"}},{"id":3476134,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-28T16:05:43.000Z","date":"2019-06-26","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":222191,"derivative":{"exercise_price":0.59,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000899243-19-018521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319018521/doc4.xml","form_type":"4"}},{"id":3476133,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-06-28T16:05:43.000Z","date":"2019-06-26","kind":"exercise","acquired":true,"shares":17000,"price":0.59,"value":10030.0,"ownership":{"direct":true},"balance_after":36470,"source":{"system":"sec-edgar","filing":"0000899243-19-018521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319018521/doc4.xml","form_type":"4"}},{"id":3497366,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-06-07T16:52:27.000Z","date":"2019-06-05","kind":"sale","acquired":false,"shares":300,"price":31.03,"value":9309.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $30.81 to $31.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":19470,"source":{"system":"sec-edgar","filing":"0000899243-19-016042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319016042/doc4.xml","form_type":"4"}},{"id":3497365,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-06-07T16:52:27.000Z","date":"2019-06-05","kind":"sale","acquired":false,"shares":13421,"price":30.1,"value":403972.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $29.79 to $30.72 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":19770,"source":{"system":"sec-edgar","filing":"0000899243-19-016042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319016042/doc4.xml","form_type":"4"}},{"id":3497364,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-06-07T16:52:27.000Z","date":"2019-06-05","kind":"sale","acquired":false,"shares":3279,"price":29.34,"value":96205.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $28.76 to $29.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":33191,"source":{"system":"sec-edgar","filing":"0000899243-19-016042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319016042/doc4.xml","form_type":"4"}},{"id":3497363,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-06-07T16:52:27.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":1769,"price":12.0105,"value":21246.5745,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2018 Employee Stock Purchase Plan."}],"balance_after":36470,"source":{"system":"sec-edgar","filing":"0000899243-19-016042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319016042/doc4.xml","form_type":"4"}},{"id":3547623,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-26T16:06:45.000Z","date":"2019-04-24","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":239191,"derivative":{"exercise_price":0.59,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-19-011239","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319011239/doc4.xml","form_type":"4"}},{"id":3547622,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-04-26T16:06:45.000Z","date":"2019-04-24","kind":"sale","acquired":false,"shares":5000,"price":26.11,"value":130550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of the shares sold ranging from $26.00 to $26.57 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":34701,"source":{"system":"sec-edgar","filing":"0000899243-19-011239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319011239/doc4.xml","form_type":"4"}},{"id":3547621,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-04-26T16:06:45.000Z","date":"2019-04-24","kind":"exercise","acquired":true,"shares":5000,"price":0.59,"value":2950.0,"ownership":{"direct":true},"balance_after":39701,"source":{"system":"sec-edgar","filing":"0000899243-19-011239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319011239/doc4.xml","form_type":"4"}},{"id":3583100,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-21T20:50:29.000Z","date":"2019-03-19","kind":"exercise","acquired":false,"shares":34662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":244191,"derivative":{"exercise_price":0.59,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":34662},"source":{"system":"sec-edgar","filing":"0000899243-19-008760","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319008760/doc4.xml","form_type":"4"}},{"id":3583099,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-21T20:50:29.000Z","date":"2019-03-19","kind":"exercise","acquired":false,"shares":10871,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.15,"exercise_date":"2017-03-06","expiration_date":"2027-03-05","underlying":"Common Stock","underlying_shares":10871},"source":{"system":"sec-edgar","filing":"0000899243-19-008760","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319008760/doc4.xml","form_type":"4"}},{"id":3583098,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-03-21T20:50:29.000Z","date":"2019-03-19","kind":"sale","acquired":false,"shares":11913,"price":19.66,"value":234209.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $19.65 to $20.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":34701,"source":{"system":"sec-edgar","filing":"0000899243-19-008760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319008760/doc4.xml","form_type":"4"}},{"id":3583097,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-03-21T20:50:29.000Z","date":"2019-03-19","kind":"exercise","acquired":true,"shares":34662,"price":0.59,"value":20450.58,"ownership":{"direct":true},"balance_after":46614,"source":{"system":"sec-edgar","filing":"0000899243-19-008760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319008760/doc4.xml","form_type":"4"}},{"id":3583096,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-03-21T20:50:29.000Z","date":"2019-03-19","kind":"exercise","acquired":true,"shares":10871,"price":0.15,"value":1630.65,"ownership":{"direct":true},"balance_after":11952,"source":{"system":"sec-edgar","filing":"0000899243-19-008760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319008760/doc4.xml","form_type":"4"}},{"id":3583095,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2019-03-21T20:50:29.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":1081,"price":12.01,"value":12982.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2018 Employee Stock Purchase Plan."}],"balance_after":1081,"source":{"system":"sec-edgar","filing":"0000899243-19-008760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319008760/doc4.xml","form_type":"4"}},{"id":3771605,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":38522,"kind":"person","name":"Siu Christine","position":1,"cik":"0001743029","reported_name":"Siu Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-07T19:11:04.000Z","date":"2018-11-05","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person is a participant in the Issuer's 2018 Stock Option and Incentive Plan and received 55,000 stock options (the \"Grant\") on November 5, 2018.  The shares subject to the Grant shall vest as follows: one quarter of the shares shall vest on November 5, 2019 and the remaining unvested shares shall vest ratably over the following 36 months, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":55000,"derivative":{"exercise_price":13.2,"expiration_date":"2028-11-05","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000899243-18-028486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924318028486/doc4.xml","form_type":"4"}}]}